American Heart Association (AHA)

The American Heart Association (AHA) funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke. The AHA also is a key resource for the latest cardiology science through its journals and annual meeting.

Takeshi Tsuda, MD, pediatric cardiologist, Nemours Children’s Health, Delaware, discusses evaluation of cardio-toxicity in pediatric cancer patients. He presented a study at American Heart Association (AHA) 2022 meeting that hoped to show the use of cardiac stress testing on children would indicate which patients would see more toxicity from chemotherapy agents. #AHA #AHA22

VIDEO: Identifying cardiotoxicity in young cancer patients

Pediatric cardiologist Takeshi Tsuda, MD, discussed the evaluation of cardiotoxicity in young cancer patients at the American Heart Association (AHA) 2022 meeting.

VIDEO: The need to develop the cardiology workforce

ACC President Edward T.A. Fry, MD, explains the need to better develop the cardiology workforce as the subspecialty faces a looming shortage of cardiologists. 

Thumbnail

World’s leading cardiology groups say it is time to rethink RCTs

The American College of Cardiology, American Heart Association, European Society of Cardiology and World Heart Federation all collaborated on a joint statement aimed at updating the rules and regulations associated with randomized clinical trials

Juan Granada discusses new cardiac technology AHA22.

VIDEO: 2 key technologies to rapidly advance cardiovascular care

Juan Granada, MD, president and CEO of the Cardiovascular Research Foundation (CRF), shares his thoughts on two key areas of technology advancements in cardiovascular imaging and neuro-interventional care for stroke.

money puzzle innovation funding

How cardiologists can steer patient discussions about costs and value in the right direction

High out-of-pocket costs are a growing problem in healthcare, often creating stress and confusion for patients. A new analysis in Circulation: Cardiovascular Quality and Outcomes examined one way that physicians can help. 

Treatments for rheumatoid arthritis, Parkinson’s disease linked to cardiovascular benefits

New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.

High copays keep many heart failure patients from filling needed prescriptions

Researchers examined data from more than 900 patients, presenting their findings in the Journal of the American Heart Association.

Early catheter ablation superior to medication when treating ventricular tachycardia storm

VT storm is associated with a heightened risk of death or significant complications. Early catheter ablation, it seems, is the most effective treatment option for this potentially fatal condition.